Published online ahead of print in the journal Oncogene , a study led by Josep Villanueva, an Investigator at the Vall d’Hebron Institute of Oncology (VHIO), shows that the receptor for advanced glycation end-product (RAGE) plays a key role in cellular mechanisms of plasticity in mesenchymal triple-negative breast cancer (TNBC) that transform epithelial cells into mesenchymal cells as potent drivers of cancer cell proliferation and tumor invasion.
What Trump and Robert F. Kennedy Jr. might do to undermine vaccines — and what they likely can’t
After Donald Trump’s victory on Tuesday, longtime vaccine skeptic Robert F. Kennedy Jr. is poised to have tremendous influence over the way the United States